These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21455713)

  • 21. Total apolipoprotein E levels and specific isoform composition in cerebrospinal fluid and plasma from Alzheimer's disease patients and controls.
    Martínez-Morillo E; Hansson O; Atagi Y; Bu G; Minthon L; Diamandis EP; Nielsen HM
    Acta Neuropathol; 2014 May; 127(5):633-43. PubMed ID: 24633805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations between TOMM40 Poly-T Repeat Variants and Dementia in Cases with Parkinsonism.
    Lindqvist D; Prokopenko I; Londos E; Middleton L; Hansson O
    J Parkinsons Dis; 2016; 6(1):99-108. PubMed ID: 26756745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms.
    Mastaglia FL; Rojana-udomsart A; James I; Needham M; Day TJ; Kiers L; Corbett JA; Saunders AM; Lutz MW; Roses AD;
    Neuromuscul Disord; 2013 Dec; 23(12):969-74. PubMed ID: 24103330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease.
    Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW;
    Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. APOE allele frequencies in suspected non-amyloid pathophysiology (SNAP) and the prodromal stages of Alzheimer's Disease.
    Hohman TJ; Dumitrescu L; Oksol A; Wagener M; Gifford KA; Jefferson AL;
    PLoS One; 2017; 12(11):e0188501. PubMed ID: 29190651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
    Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
    Kim S; Swaminathan S; Shen L; Risacher SL; Nho K; Foroud T; Shaw LM; Trojanowski JQ; Potkin SG; Huentelman MJ; Craig DW; DeChairo BM; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
    Neurology; 2011 Jan; 76(1):69-79. PubMed ID: 21123754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors that influence the levels of cerebrospinal fluid biomarkers in memory clinic patients.
    Knapskog AB; Eldholm RS; Braekhus A; Engedal K; Saltvedt I
    BMC Geriatr; 2017 Sep; 17(1):210. PubMed ID: 28893185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE ε4 variant.
    Burggren AC; Mahmood Z; Harrison TM; Siddarth P; Miller KJ; Small GW; Merrill DA; Bookheimer SY
    Alzheimers Dement; 2017 Jul; 13(7):739-748. PubMed ID: 28183529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. APOE ε4 is associated with higher levels of CSF SNAP-25 in prodromal Alzheimer's disease.
    Wang S; Zhang J; Pan T;
    Neurosci Lett; 2018 Oct; 685():109-113. PubMed ID: 30144541
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal modeling of cognitive aging and the TOMM40 effect.
    Caselli RJ; Dueck AC; Huentelman MJ; Lutz MW; Saunders AM; Reiman EM; Roses AD
    Alzheimers Dement; 2012 Nov; 8(6):490-5. PubMed ID: 23102119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
    Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
    Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
    Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
    Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stability of CSF beta-amyloid(1-42) and tau levels by APOE genotype in Alzheimer patients.
    Huey ED; Mirza N; Putnam KT; Soares H; Csako G; Levy JA; Copenhaver B; Cohen RM; Sunderland T
    Dement Geriatr Cogn Disord; 2006; 22(1):48-53. PubMed ID: 16682793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
    Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TOMM40 poly-T repeat lengths, age of onset and psychosis risk in Alzheimer disease.
    Chu SH; Roeder K; Ferrell RE; Devlin B; DeMichele-Sweet MA; Kamboh MI; Lopez OL; Sweet RA
    Neurobiol Aging; 2011 Dec; 32(12):2328.e1-9. PubMed ID: 21820212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals.
    Alemany S; Crous-Bou M; Vilor-Tejedor N; Milà-Alomà M; Suárez-Calvet M; Salvadó G; Cirach M; Arenaza-Urquijo EM; Sanchez-Benavides G; Grau-Rivera O; Minguillon C; Fauria K; Kollmorgen G; Domingo Gispert J; Gascón M; Nieuwenhuijsen M; Zetterberg H; Blennow K; Sunyer J; Luis Molinuevo J;
    Environ Int; 2021 Dec; 157():106864. PubMed ID: 34537521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.